Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Virtual Booth

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

2DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 154652-83-2, Tezampanel (anhydrous), Ly-293558, Ly293558, 150131-78-5, Tezampanel [inn]

Molecular Formula

C₁₃H₂₁N₅O₂

Molecular Weight

279.34 g/mol

InChI Key

ZXFRFPSZAKNPQQ-YTWAJWBKSA-N

FDA UNII

GA36S2O9C2

Tezampanel is an AMPA receptor antagonist.

1 2D Structure

Tezampanel

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(3S,4aR,6R,8aR)-6-[2-(2H-tetrazol-5-yl)ethyl]-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic acid

2.1.2 InChI

InChI=1S/C13H21N5O2/c19-13(20)11-6-10-5-8(1-3-9(10)7-14-11)2-4-12-15-17-18-16-12/h8-11,14H,1-7H2,(H,19,20)(H,15,16,17,18)/t8-,9+,10-,11+/m1/s1

2.1.3 InChI Key

ZXFRFPSZAKNPQQ-YTWAJWBKSA-N

2.1.4 Canonical SMILES

C1CC2CNC(CC2CC1CCC3=NNN=N3)C(=O)O

2.1.5 Isomeric SMILES

C1C[C@H]2CN[C@@H](C[C@H]2C[C@H]1CCC3=NNN=N3)C(=O)O

2.2 Other Identifiers

2.2.1 UNII

GA36S2O9C2

2.3 Synonyms

2.3.1 MeSH Synonyms

1. (3s,4ar,6r,8ar)-6-(2-(1(2)h-tetrazole-5yl)ethyl)decahydroisoquinoline-3carboxylic Acid

2. 6-(2-(1h-tetrazol-5-yl)ethyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic Acid

3. Ly 215490

4. Ly 293558

5. Ly 326325

6. Ly-215490

7. Ly-293558

8. Ly-326325

9. Ly293558

10. Ngx424

2.3.2 Depositor-Supplied Synonyms

1. 154652-83-2

2. Tezampanel (anhydrous)

3. Ly-293558

4. Ly293558

5. 150131-78-5

6. Tezampanel [inn]

7. Tezampanel, Anhydrous

8. Ly 293558

9. Ngx-424

10. Ly-293,558

11. 6-(2-(1h-tetrazol-5-yl)ethyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic Acid

12. Chembl14935

13. Ga36s2o9c2

14. (3s,4ar,6r,8ar)-6-[2-(2h-tetrazol-5-yl)ethyl]-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic Acid

15. 154652-83-2 (anhydrous)

16. (3s,4ar,6r,8ar)-6-(2-(1h-tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic Acid

17. Ted-isoquinoline-3-cooh

18. Unii-ga36s2o9c2

19. Ly215490

20. Decahydro-6-(2-(1h-tetrazol-5-yl)ethyl)-3-isoquinolinecarboxylic Acid

21. Tezampanel Anhydrous

22. Gtpl4245

23. Schembl1649338

24. Bdbm86751

25. Zinc5134714

26. Bdbm50494341

27. Cs-0821

28. Db06354

29. 3-isoquinolinecarboxylic Acid, Decahydro-6-(2-(1h-tetrazol-5-yl)ethyl)-, (3s,4ar,6r,8ar)-

30. Ncgc00378884-01

31. 3-isoquinolinecarboxylic Acid, Decahydro-6-(2-(1h-tetrazol-5-yl)ethyl)-, (3s-(3alpha,4aalpha,6beta,8aalpha))-

32. Hy-75704

33. Q7708612

34. (3s,4ar,6r,8ar)-6-[2-(1h-1,2,3,4-tetrazol-5-yl)ethyl]-decahydroisoquinoline-3-carboxylic Acid

35. (3s,4ar,6r,8ar)-6-[2-(2h-1,2,3,4-tetrazol-5-yl)ethyl]-decahydroisoquinoline-3-carboxylic Acid

36. (3s,4as,6r,8as)-6-(2-(1h-tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic Acid

37. 3-isoquinolinecarboxylic Acid, Decahydro-6-(2-(1h-tetrazol-5-yl)ethyl)-, (3s,4as,6r,8as)-

2.4 Create Date

2005-08-08

3 Chemical and Physical Properties

Molecular Formula	C₁₃H₂₁N₅O₂
Molecular Weight	279.34 g/mol
XLogP3	-0.8
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	6
Rotatable Bond Count	4
Exact Mass	279.16952493 g/mol
Monoisotopic Mass	279.16952493 g/mol
Topological Polar Surface Area	104 Å²
Heavy Atom Count	20
Formal Charge	0
Complexity	354
Isotope Atom Count	0
Defined Atom Stereocenter Count	4
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Indication

Investigated for use/treatment in pain (acute or chronic) and migraine and cluster headaches.

5 Pharmacology and Biochemistry

5.1 Mechanism of Action

NGX426 is a prodrug of tezampanel (NGX424). Tezampanel is an antagonist that binds to glutamate kainate (Glu K5) receptors, inhibiting excitatory synapases the brain.

Drugs in Development